Fundraising FoxAnTolRx
Boston, US · Founded 2015 · Delaware corporation · 1 known investors
Find your way into AnTolRx
Sign up to see every warm intro you have to AnTolRx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AnTolRx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AnTolRx develops immunotherapy therapeutics based on research in immune tolerance, targeting immune-mediated disorders. The company is led by scientists and industry veterans with expertise in drug development and biotechnology commercialization.
Founders & leadership
AnTolRx was founded in 2015 by Francisco J. Quintana.
FJ
Francisco J. QuintanaScientific Founder, Member of Board of Directors
MC
Mark CarthyFounder and CEO, Member of Board of Directors
Board
SJ
Satish JindalBoard director
Investors · 1
RiverVest Venture PartnersreportedSt. Louis · $500K – $3M
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2016
▶$1MraisedJul 2016 · 3 investors · BiotechnologyRule 506(b)
▶$1MraisedJul 2016 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Satish JindalDirector
- Francisco QuintanaDirector
- Mark CarthyExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Mission BioCapital Platinum Program Holdings LLCMission BioCapital is a venture capital firm that invests in early-stage life science companies, from therapeutics and drug discovery to biotech tools and diagnostics. The firm provides capital, operational support, and lab infrastructure through its MBC BioLabs co-working spaces to help scientific entrepreneurs launch and scale biotech startups.
TellBioTellBio is a biotechnology company founded by leading cancer researchers and clinicians from Harvard Medical School and Massachusetts General Hospital. The company focuses on oncology research and development, leveraging circulating tumor cell (CTC) technology and biomedical engineering.
Companies working in the same space as AnTolRx.
Frequently asked questions
- What does AnTolRx do?
- AnTolRx develops immunotherapy therapeutics based on research in immune tolerance, targeting immune-mediated disorders. The company is led by scientists and industry veterans with expertise in drug development and biotechnology commercialization.
- Who founded AnTolRx?
- AnTolRx was founded by Francisco J. Quintana in 2015.
- Who are AnTolRx's investors?
- AnTolRx's investors include RiverVest Venture Partners.
- How much funding has AnTolRx raised?
- AnTolRx has disclosed $1M raised across 1 round.
- Where is AnTolRx headquartered?
- AnTolRx is headquartered in Boston, US.